GSK Aktie
20,48
EUR
+0,82
EUR
+4,14
%
17,88
GBP
+0,28
GBP
+1,56
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Diese Analysten bewerten die GSK-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Jefferies & Company Inc. | 21,00 GBP | - | 19.11.2025 | |
| JP Morgan Chase & Co. | 15,00 GBP | - | 07.11.2025 | |
| Bernstein Research | 22,50 GBP | - | 05.11.2025 | |
| Deutsche Bank AG | 16,00 GBP | - | 04.11.2025 | |
| DZ BANK | - | - | 30.10.2025 | |
| UBS AG | 19,00 GBP | - | 30.10.2025 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 16,00 GBP | - | 17.09.2025 | |
| Goldman Sachs Group Inc. | 15,60 GBP | - | 21.07.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Bayer | 2 | 7 | 0 | 27,36 EUR | -0,64% |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 5 | 1 | 17,87 GBP | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 5 | 2 | 0 | 141,33 EUR | +26,24% |
| Novartis AG | 3 | 4 | 2 | 101,38 CHF | -1,46% |
| Perrigo Company | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +17,13% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 8 | 1 | 0 | 107,38 EUR | +24,63% |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |